BillionToOne (BLLN) Non-Current Deffered Revenue (2025)
BillionToOne's (BLLN) quarterly Non-Current Deffered Revenue came in at $1.3 million in Q4 2025.
Powered by 
Analysis
BillionToOne (BLLN) Non-Current Deffered Revenue (2025) Analysis & Trends
BillionToOne has disclosed Non-Current Deffered Revenue across 1 years of filings, most recently posting $1.3 million for Q4 2025.
- In Q4 2025, Non-Current Deffered Revenue changed N/A year-over-year to $1.3 million; the TTM figure through Dec 2025 stood at $1.3 million (changed N/A YoY), while the FY2025 annual figure was $1.3 million, changed N/A from the prior year.
- Non-Current Deffered Revenue came in at $1.3 million for Q4 2025 at BillionToOne.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $1.3 million in Q4 2025 to a low of $1.3 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn | 16.07 Mn |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn | - |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn | - |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn | - |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn | 22.08 Mn |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn | - |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn | 16.19 Mn |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn | - |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn | 608,000.00 |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn | - |